Involvement of supraspinal and spinal CCK receptors in the modulation of antinociception induced by cold water swimming stress in the mouse.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Neuropeptides

• Publication date

  1996-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0143-4179(96)90028-1PMID 8914865
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Involvement of different subtypes of cholecystokinin receptors in opioid antinociception in the mouse.

  1995cited by this paper
• Cold water swim stress- and delta-2 opioid-induced analgesia are modulated by spinal gamma-aminobutyric acidA receptors.

  1995cited by this paper
• The effects of protection by D-Pen2-D-Pen5-enkephalin or D-Ala2-NMePhe4-Gly-ol-enkephalin against β-chlornaltrexamine in the spinal cord on the antinociception induced by β-endorphin administered intracerebroventricularly in the mouse

  1994cited by this paper
• The effects of protection by D-Pen2-D-Pen5-enkephalin or D-Ala2-NMePhe4-Gly-ol-enkephalin against beta-chlornaltrexamine in the spinal cord on the antinociception induced by beta-endorphin administered intracerebroventricularly in the mouse.

  1994cited by this paper
• Modulation of morphine antinociception by swim-stress in the mouse: involvement of supraspinal opioid delta-2 receptors.

  1993cited by this paper
• Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity.

  1990cited by this paper
• Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.

  1990cited by this paper
• Tolerance to δ-but not μ-opioid receptors in the spinal cord attenuates inhibition of the tail-flick response induced by β-endorphin administered intracerebroventricularly in mice

  1990cited by this paper
• Cholecystokinin octapeptide antagonized opioid analgesia mediated by μ- and κ- but not δ-receptors in the spinal cord of the rat

  1990cited by this paper
• Cholecystokinin octapeptide antagonized opioid analgesia mediated by mu- and kappa- but not delta-receptors in the spinal cord of the rat.

  1990cited by this paper
• Tolerance to delta- but not mu-opioid receptors in the spinal cord attenuates inhibition of the tail-flick response induced by beta-endorphin administered intracerebroventricularly in mice.

  1990cited by this paper
• Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK antagonist MK-329.

  1989cited by this paper
• Cholecystokinin-octapeptide antagonizes morphine analgesia in periaqueductal gray of the rat.

  1989cited by this paper
• Antinociceptive action of cholecystokinin octapeptide (CCK 8) and related peptides in rats and mice: effects of naloxone and peptidase inhibitors.

  1987cited by this paper
• Antinociceptive profile of sulfated CCK-8. Comparison with CCK-4, unsulfated CCK-8 and other neuropeptides.

  1986cited by this paper
• Differentiation of central and peripheral cholecystokinin receptors by new glutaramic acid derivatives with cholecystokinin-antagonistic activity.

  1986cited by this paper
• Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide.

  1985cited by this paper
• Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates.

  1985cited by this paper
• Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide.

  1984cited by this paper
• Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia.

  1983cited by this paper
• Caerulein and cholecystokinin suppress beta-endorphin-induced analgesia in the rat.

  1982cited by this paper
• Caerulein and cholecystokinin suppress β-endorphin-induced analgesia in the rat

  1982cited by this paper
• Antinociceptive effect of centrally administered caerulein and cholecystokinin octapeptide (CCK-8)☆

  1981cited by this paper
• Analgesia and ptosis caused by caerulein and cholecystokinin octapeptide (CCK-8).

  1980cited by this paper
• Intrathecal morphine in mice: a new technique.

  1980cited by this paper
• Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse.

  1957cited by this paper
• A METHOD FOR DETERMINING LOSS OF PAIN SENSATION

  1941cited by this paper

• Anxiogenic Effect of Cholecystokinin in the Dorsal Periaqueductal Gray

  2004cites this paper
• Development of antinociceptive tolerance and changes of opioid receptor ligand binding in central nervous system of the mouse forced to single and repeated swimming in the cold water.

  2003cites this paper
• Descending control of pain.

  2002cites this paper
• Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat

  2000cites this paper
• Intracerebroventricular injection-induced increase in plasma corticosterone levels in the mouse: a stress model.

  1998cites this paper
• Endogenous opiates: 1996.

  1997cites this paper